Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2018 1
2019 1
2020 1
2021 7
2022 7
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

17 results

Results by year

Filters applied: . Clear all
Page 1
Prognosis of unexpected positive intraoperative cultures in arthroplasty revision: A large multicenter cohort.
Mancheño-Losa M, Lora-Tamayo J, Fernández-Sampedro M, Rodríguez-Pardo D, Muñoz-Mahamud E, Soldevila L, Palou M, Barbero JM, Del Toro MD, Iribarren JA, Sobrino B, Rico-Nieto A, Guío-Carrión L, Gómez L, Escudero-Sánchez R, García-País MJ, Jover-Sáenz A, Praena J, Baraia-Etxaburu JM, Auñón Á, Múñez-Rubio E, Murillo O; List of study collaborators. Mancheño-Losa M, et al. J Infect. 2021 Nov;83(5):542-549. doi: 10.1016/j.jinf.2021.09.001. Epub 2021 Sep 9. J Infect. 2021. PMID: 34509512
Strain-to-strain variability among Staphylococcus aureus causing prosthetic joint infection drives heterogeneity in response to levofloxacin and rifampicin.
Meléndez-Carmona MÁ, Mancheño-Losa M, Ruiz-Sorribas A, Muñoz-Gallego I, Viedma E, Chaves F, Van Bambeke F, Lora-Tamayo J. Meléndez-Carmona MÁ, et al. Among authors: mancheno losa m. J Antimicrob Chemother. 2022 Nov 28;77(12):3265-3269. doi: 10.1093/jac/dkac311. J Antimicrob Chemother. 2022. PMID: 36124848
A multicenter randomized open-label clinical trial for convalescent plasma in patients hospitalized with COVID-19 pneumonia.
Avendaño-Solá C, Ramos-Martínez A, Muñez-Rubio E, Ruiz-Antorán B, Malo de Molina R, Torres F, Fernández-Cruz A, Calderón-Parra J, Payares-Herrera C, Díaz de Santiago A, Romera-Martínez I, Pintos I, Lora-Tamayo J, Mancheño-Losa M, Paciello ML, Martínez-González AL, Vidán-Estévez J, Nuñez-Orantos MJ, Saez-Serrano MI, Porras-Leal ML, Jarilla-Fernández MC, Villares P, de Oteyza JP, Ramos-Garrido A, Blanco L, Madrigal-Sánchez ME, Rubio-Batllés M, Velasco-Iglesias A, Paño-Pardo JR, Moreno-Chulilla JA, Muñiz-Díaz E, Casas-Flecha I, Pérez-Olmeda M, García-Pérez J, Alcamí J, Bueno JL, Duarte RF; ConPlas-19 Study Group. Avendaño-Solá C, et al. Among authors: mancheno losa m. J Clin Invest. 2021 Oct 15;131(20):e152740. doi: 10.1172/JCI152740. J Clin Invest. 2021. PMID: 34473652 Free PMC article. Clinical Trial.
Prime-Boost Vaccination With BNT162b2 Induces High Neutralizing Activity Against SARS-CoV-2 Variants in Naïve and COVID-19-Convalescent Individuals.
Luczkowiak J, Labiod N, Rivas G, Rolo M, Lasala F, Lora-Tamayo J, Mancheno-Losa M, Rial D, Pérez-Rivilla A, Folgueira MD, Delgado R. Luczkowiak J, et al. Among authors: mancheno losa m. Open Forum Infect Dis. 2021 Sep 24;8(10):ofab468. doi: 10.1093/ofid/ofab468. eCollection 2021 Oct. Open Forum Infect Dis. 2021. PMID: 34642637 Free PMC article.
17 results